[1] Dubula T, Mody GM (2015) Spectrum of infections and outcome
among hospitalized South Africans with systemic lupus erythematosus. Clin Rheumatol 34(3):479–488
[2] Wu L, Wang X, Chen F, et al. (2017) T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients. Braz J Med Biol Res 51(2):e4547
[3] Jung JY, Suh CH (2017) Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med 32(3):429–438.
[4] Morris A, Norris ΚΑ. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev. 2012;25:297-317.
[5] Matsumura Y, Shindo Y, Iinuma Y et al. Clinical characteristics of Pneumocystis pneumonia in non- HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis. 2011;11:76.
[6] Monnet X, Vidal-Petiot E, Osman D et al.Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care. 2008;12:R28.
[7] Pereira-Diaz E, et al. Changing Trends in the Epidemiology and Risk Factors of Pneumocystis Pneumonia in Spain. Front Public Health. 2019;7:275. doi:10.3389/fpubh.2019.00275.
[8] Maini R, et al . Emerg Infect Dis.2013);19:386-92. doi:10.3201/eid1903.121151
[9] Rashid R, Denning DW: Invasive pulmonary aspergillosis 10 years post bone marrow transplantation: A case report. J Med Case Rep 2009;3:26.
[10] Baumann S, Reinwald M, Haghi D et al. Coinfection of Pneumocystis
jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge. Onkologie. 2013;36:582-584.
[11] Anthi-Marina Markantonatou, Aliki Ioakimidou, Kostoula Arvaniti et al. Pulmonary co- infections by Pneumocystis jiroveciiand Aspergillus fumigatusin non- HIV patients: A report of two cases and literature review. Mycoses. 2017;60:626–633.
[12] J. Peter Donnelly et al.Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.Clin. Infect. Dis. 2019 Dec 05; DOI:10.1093/cid/ciz1008.
[13] Chengcheng Hou, Ou Jin, Xi Zhang. Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus.Clinical Rheumatology(2018) 37:2699–2705.
[14] Jeong SJ, Choi H, Lee HS, Han SH, Chin BS, Baek JH, Kim CO,Choi JY, Song YG, Kim JM (2009) Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus. Scand J Infect Dis 41(4):268–274.
[15] Yunyun Fei, Xiaochun Shi, Fengying Gan, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol (2014) 33:57–63.
[16] Walsh TJ, Anaissie EJ, Denning DW, et al: Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society Of America. Clin Infect Dis 2008;46:327–360.
[17] Gilroy SA, Bennett NJ: Pneumocystis pneumonia. Semin Respir Crit Care Med 2011;32:775–782.
[18] Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M: Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society Of Hematology And Oncology (DGHO). Ann Hematol 2013;92:433–442.
[19] Lecuit M, Eloit M. The diagnosis of infectious diseases by whole genome next generation sequencing: a new era is opening. Front Cell Infect Microbiol. 2014;4:25
[20] Asai N, Motojima S, Ohkuni Y, Matsunuma R, Nakashima K, Iwasaki T, Nakashita T, Otsuka Y, Kaneko N: Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection. J Infect Chemother 2012;18:898–905.
[21] Jacob HJ. Next-generation sequencing for clinical diagnostics. N Engl J Med. 2013;369(16):1557–8.
[22] Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370(25):2408–17.
[23] Grumaz S, Stevens P, Grumaz C, et al. Next-generation sequencing diagnostics of bacteremia in septic patients. Genome Med. 2016;8(1):73.
[24] Kawada J, Okuno Y, Torii Y, et al. Identification of viruses in cases of pediatric acute encephalitis and encephalopathy using next-generation sequencing. Sci Rep. 2016;6:33452.
[25] Cordey S, Brito F, Vu DL, et al. Astrovirus VA1 identified by next-generation sequencing in a nasopharyngeal specimen of a febrile Tanzanian child with acute respiratory disease of unknown etiology. Emerg Microbes Infec. 2016;5(9):e99.
[26] Thorburn F, Bennett S, Modha S, et al. The use of next generation sequencing in the diagnosis and typing of respiratory infections. J Clin Virol. 2015;69:96–100.
[27] Zhang Y, Ai J, Cui P, Zhang W, Wu H, Ye M. 2019. A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach. J Infection. 78(2):158–169.
[28] Fan S, Qiao X, Liu L, Wu H, Zhou J, Sun R, Chen Q, Huang Y,Mao C, Yuan J, et al. 2018. Next-generation sequencing of cerebrospinal fluid for the diagnosis of neurocysticercosis. Front Neurol. 9:471.
[29]Ye M, Wei W, Yang Z, Li Y, Cheng S, Wang K, Zhou T, Sun J,Liu S, Ni N, et al. 2015. Rapid diagnosis of Propionibacterium acnes infection in patient with hyperpyrexia after hematopoietic stem cell transplantation bynext-generation sequencing: a case report. BMC Infect Dis.16(1):5.
[30] Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1000 patients. European Working Party on Systemic Lupus Erythematosus [ J ]. Medicine, 1999, 78( 3): 167- 175.
[31] Mok CC, Lee KW, Ho CT, et al. A prospective study of survival and pro gnostic indicators of systemic lupus erythematosus in a southern Chinese population [ J] . Rheumatology ( Oxford), 2000, 39(4): 399- 406.